209 related articles for article (PubMed ID: 23970480)
1. Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry.
Jackson W; Alexander N; Schipper M; Fig L; Feng F; Jolly S
Head Neck; 2014 Sep; 36(9):1356-62. PubMed ID: 23970480
[TBL] [Abstract][Full Text] [Related]
2. Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.
Lonkvist CK; Lønbro S; Vinther A; Zerahn B; Rosenbom E; Primdahl H; Hojman P; Gehl J
BMC Cancer; 2017 Jun; 17(1):400. PubMed ID: 28578654
[TBL] [Abstract][Full Text] [Related]
3. Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer.
Lin YC; Ling HH; Chang PH; Pan YP; Wang CH; Chou WC; Chen FP; Yeh KY
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578846
[TBL] [Abstract][Full Text] [Related]
4. Accelerated loss of lean body mass in head and neck cancer patients during cisplatin-based chemoradiation.
Lønbro S; Gam S; Hermann AP; Hansen CR; Johansen J
Acta Oncol; 2023 Nov; 62(11):1403-1411. PubMed ID: 37589161
[TBL] [Abstract][Full Text] [Related]
5. Effect of Chemotherapy on Dual-Energy X-ray Absorptiometry (DXA) Body Composition Precision Error in Head and Neck Cancer Patients.
Chang HC; Lin YC; Ng SH; Cheung YC; Wang CH; Chen FP; Chang HP; Sung CM; Fan CM; Yeh KY; Wu JS
J Clin Densitom; 2019; 22(3):437-443. PubMed ID: 30172603
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
7. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy.
Silver HJ; Dietrich MS; Murphy BA
Head Neck; 2007 Oct; 29(10):893-900. PubMed ID: 17405169
[TBL] [Abstract][Full Text] [Related]
8. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
[TBL] [Abstract][Full Text] [Related]
9. [Nutritional surveillance in head and neck cancer patients during radiotherapy--the difference between concurrent chemoradiotherapy using high-dose cisplatin and radiotherapy alone].
Nakahara S; Yoshino K; Fujii T; Uemura H; Suzuki M; Nishiyama K; Inohara H
Nihon Jibiinkoka Gakkai Kaiho; 2012 Oct; 115(10):902-9. PubMed ID: 23214048
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways.
Platek ME; Myrick E; McCloskey SA; Gupta V; Reid ME; Wilding GE; Cohan D; Arshad H; Rigual NR; Hicks WL; Sullivan M; Warren GW; Singh AK
Support Care Cancer; 2013 Oct; 21(10):2825-33. PubMed ID: 23743980
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.
Kimura H; Hamauchi S; Kawai S; Onozawa Y; Yasui H; Yamashita A; Ogawa H; Onoe T; Kamijo T; Iida Y; Onitsuka T; Yokota T
Int J Clin Oncol; 2020 Feb; 25(2):258-266. PubMed ID: 31620932
[TBL] [Abstract][Full Text] [Related]
12. Progressive resistance training in head and neck cancer patients undergoing concomitant chemoradiotherapy.
Lonkvist CK; Vinther A; Zerahn B; Rosenbom E; Deshmukh AS; Hojman P; Gehl J
Laryngoscope Investig Otolaryngol; 2017 Oct; 2(5):295-306. PubMed ID: 29094074
[TBL] [Abstract][Full Text] [Related]
13. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K
Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797
[TBL] [Abstract][Full Text] [Related]
14. Prospective clinical study on long-term swallowing function and voice quality in advanced head and neck cancer patients treated with concurrent chemoradiotherapy and preventive swallowing exercises.
Kraaijenga SA; van der Molen L; Jacobi I; Hamming-Vrieze O; Hilgers FJ; van den Brekel MW
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3521-31. PubMed ID: 25381096
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the pretreatment geriatric nutritional risk index for predicting severe adverse events in patients with head and neck cancer treated with chemoradiotherapy.
Nakayama M; Ohnishi K; Adachi M; Ii R; Matsumoto S; Nakamura M; Miyamoto H; Hirose Y; Nishimura B; Tanaka S; Wada T; Tabuchi K
Auris Nasus Larynx; 2022 Apr; 49(2):279-285. PubMed ID: 34509306
[TBL] [Abstract][Full Text] [Related]
17. Acoustic analysis of voice in nonlaryngeal head and neck cancer patients post chemoradiotherapy.
Radhakrishna N; Yamini BK; Kadam AS; Shivashankar N; Vishwanathan C; Javarappa R
J Cancer Res Ther; 2017; 13(1):113-117. PubMed ID: 28508843
[TBL] [Abstract][Full Text] [Related]
18. Body composition changes in patients with head and neck cancer under active treatment: a scoping review.
Ferrão B; Neves PM; Santos T; Capelas ML; Mäkitie A; Ravasco P
Support Care Cancer; 2020 Oct; 28(10):4613-4625. PubMed ID: 32533436
[TBL] [Abstract][Full Text] [Related]
19. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
[No Abstract] [Full Text] [Related]
20. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
